SPVZX | VMVAX | SPVZX / VMVAX | |
Total Expense Ratio | 0.89 | 0.07 | 1,271% |
Annual Report Gross Expense Ratio | 1.00 | 0.07 | 1,429% |
Fund Existence | 20 years | 14 years | - |
Gain YTD | 9.680 | 7.952 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 166M | 32.5B | 1% |
Annual Yield % from dividends | 1.52 | 2.17 | 70% |
Returns for 1 year | 8.32 | 4.87 | 171% |
Returns for 3 years | 46.73 | 42.44 | 110% |
Returns for 5 years | 95.09 | 64.89 | 147% |
Returns for 10 years | 52.49 | 102.58 | 51% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFAK | 132.05 | N/A | N/A |
Stone Ridge 2052 Longevity Income ETF | |||
OVB | 20.58 | -0.03 | -0.15% |
Overlay Shares Core Bond ETF | |||
FIDI | 24.52 | -0.12 | -0.48% |
Fidelity International High Div ETF | |||
EMXC | 68.93 | -0.53 | -0.76% |
iShares MSCI Emerging Mkts ex China ETF | |||
EQAL | 52.25 | -0.44 | -0.84% |
Invesco Russell 1000 Equal Weight ETF |